Cargando…
TROPONIN, ANTICOAGULATION, ATRIAL FIBRILLATION AND CORONAVIRUS DISEASE 19 IN PATIENTS WITH UNDERLYING CARDIAC DISEASE
Autores principales: | Limani, Saurabhkumar M., Desai, Nayan Kirit, Yamini, Sundermurthy, Sturdevant, David, Feltman, Erin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Cardiology Foundation. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982901/ http://dx.doi.org/10.1016/S0735-1097(23)02604-9 |
Ejemplares similares
-
A Rare but Deadly Complication of Transcatheter Aortic Valve Replacement
por: Limani, Saurabhkumar M, et al.
Publicado: (2022) -
THE IMPACT OF ORAL ANTICOAGULANTS ON THE OUTCOMES OF COVID-19 PATIENTS WITH A HISTORY OF HF AND ATRIAL FIBRILLATION
por: Zadeh, Ali Vaeli, et al.
Publicado: (2022) -
ATRIAL FIBRILLATION AND MORTALITY IN COVID-19 PATIENTS
por: Wang, Lucas, et al.
Publicado: (2022) -
NEW-ONSET ATRIAL FIBRILLATION DURING HOSPITALIZATION FOR COVID-19 PATIENTS WITHOUT PREEXISTING CARDIOVASCULAR DISEASE
por: Wang, Suwei, et al.
Publicado: (2021) -
EFFECTS OF ELEVATED TROPONIN ON MORTALITY IN HOSPITALIZED COVID-19 PATIENTS WITH AND WITHOUT CORONARY ARTERY DISEASE
por: Zhao, Yi, et al.
Publicado: (2022)